Meetings and operational procedures
The MPAC meets twice a year for three days, with dates generally set two years in advance. The frequency and duration of meetings may be adjusted as necessary. MPAC recommendations are, as a rule, taken by consensus. In the exceptional situation that a consensus on a particular issue cannot be reached, the Chairperson is asked to report the majority and minority views. It is also the Chairperson’s responsibility to ensure there is clarity for MPAC members on what exactly is being decided.
Representatives of the Roll Back Malaria Partnership Secretariat (RBM), the Global Fund to Fight AIDS, Tuberculosis and Malaria, UNICEF and the Office of the United Nations Special Envoy for Malaria are invited to participate as observers in MPAC meetings and deliberations. Relevant staff from WHO Headquarters and Regional Offices attend as members of the Secretariat. In addition, up to seven National Malaria Control Programme managers from around the world are invited as resource persons to observe and participate in the meetings.
WHO/GMP may also invite other observers to MPAC meetings, including representatives from WHO regional technical advisory groups, non-governmental organizations (NGOs), international professional organizations, technical agencies, and donor organizations. Additional experts and Technical Resource Persons, may also be invited to meetings, as appropriate, to further contribute to specific agenda items. Other observers are welcome to attend MPAC meetings on their own initiative.
Registration for observers generally begins six weeks before each scheduled meeting. Observers shall not take the floor unless requested to do so by the Chairperson and shall under no circumstances participate in the formulation of MPAC recommendations.
The MPAC is kept informed by WHO/GMP and partner agencies of progress in the implementation of WHO’s global recommendations, and the attainment of objectives at country and regional level. WHO/GMP, together with the MPAC Chairperson, determines which policy issues, and information from other WHO technical advisory groups, should be brought to the attention of the MPAC.
In developing its priorities of work and meeting agendas, the MPAC works with WHO/GMP, and input is also solicited from malaria-endemic countries. In time, it is possible a wider group will be invited to contribute to agenda items in advance of each meeting via open consultation on the WHO/GMP website.
Under the auspices of the MPAC, three standing Technical Expert Groups (TEGs) have been established: on Chemotherapy, on Drug Resistance and Containment, and on Vector Control. In addition, time-limited and specific Evidence Review Groups (ERGs) may be established to review and provide evidence-based information and options for recommendations. Recommendations emerging from the TEGs and ERGs are discussed by the full MPAC in open sessions.
In order to seek broader input and allow for the exchange of information and views and to ensure transparency and inclusivity, the majority of discussions occur in open sessions. However, the actual deliberations and development of MPAC recommendations take place in closed sessions in order to protect the integrity and independence of the committee from pressure and undue influence.
Transparency is ensured, however, as all MPAC recommendations and conclusions are published on this website, and a detailed report of each meeting is published in the Malaria Journal. Approved meeting agendas, documents, minutes and recommendations are archived and continue to remain publicly available and easily accessible on the WHO/GMP website.
The MPAC reports to the WHO Director-General (or designee), and the MPAC Chairperson debriefs the WHO Director-General (or designee) and the Director of WHO/GMP following each MPAC meeting.
MPAC members are not remunerated for their participation in MPAC. However, reasonable expenses such as travel expenses incurred by attendance at MPAC or related meetings are compensated by WHO in accordance with applicable rules and policies.